The role of DNA hypomethylation, histone acetylation and in vivo protein-DNA binding in Epstein-Barr virus-induced CD23 upregulation.
暂无分享,去创建一个
J. Minárovits | N. Nagy | E. Klein | D. Salamon | H. Niller | F. Bánáti | K. Szenthe | H. Wolf | Anita Koroknai | Z. Bathori
[1] S. Pileri,et al. Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes. , 2010, Blood.
[2] B. Ozanne,et al. CD23/FcεRII: molecular multi‐tasking , 2010, Clinical and experimental immunology.
[3] J. Minárovits,et al. Binding of CCCTC-binding factor in vivo to the region located between Rep* and the C promoter of Epstein-Barr virus is unaffected by CpG methylation and does not correlate with Cp activity. , 2009, The Journal of general virology.
[4] J. Minárovits,et al. Latency type-specific distribution of epigenetic marks at the alternative promoters Cp and Qp of Epstein-Barr virus. , 2008, The Journal of general virology.
[5] J. Minárovits,et al. Acetylated Histone H3 and H4 Mark the Upregulated LMP2A Promoter of Epstein-Barr Virus in Lymphoid Cells , 2007, Journal of Virology.
[6] W. Lucchesi,et al. Cell target genes of Epstein-Barr virus transcription factor EBNA-2: induction of the p55alpha regulatory subunit of PI3-kinase and its role in survival of EREB2.5 cells. , 2006, The Journal of general virology.
[7] S. Pileri,et al. Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas. , 2005, Blood.
[8] J. Minárovits,et al. Epigenetic regulation of lymphoid specific gene sets. , 2005, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[9] L. Verdone,et al. Role of histone acetylation in the control of gene expression. , 2005, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[10] P. Lieberman,et al. Dynamic Chromatin Boundaries Delineate a Latency Control Region of Epstein-Barr Virus , 2004, Journal of Virology.
[11] J. Minárovits,et al. High-resolution Methylation Analysis and In Vivo Protein–DNA Binding at the Promoter of the Viral Oncogene LMP2A in B Cell Lines Carrying Latent Epstein–Barr Virus Genomes , 2003, Virus Genes.
[12] H. Gruffat,et al. Differential Hyperacetylation of Histones H3 and H4 upon Promoter-Specific Recruitment of EBNA2 in Epstein-Barr Virus Chromatin , 2003, Journal of Virology.
[13] B. Ozanne,et al. The CD23a and CD23b proximal promoters display different sensitivities to exogenous stimuli in B lymphocytes , 2002, Genes and Immunity.
[14] A. Rickinson. Epstein-Barr virus. , 2001, Virus research.
[15] J. Minárovits,et al. Protein-DNA Binding and CpG Methylation at Nucleotide Resolution of Latency-Associated Promoters Qp, Cp, and LMP1p of Epstein-Barr Virus , 2001, Journal of Virology.
[16] J. Minárovits,et al. Epigenetics of Latent Epstein-Barr Virus Genomes: High Resolution Methylation Analysis of the Bidirectional Promoter Region of Latent Membrane Protein 1 and 2B Genes , 2001, Biological chemistry.
[17] J. Hsieh,et al. A Role for SKIP in EBNA2 Activation of CBF1-Repressed Promoters , 2000, Journal of Virology.
[18] E. Kieff,et al. Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[19] J. Hsieh,et al. CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[20] J. Lacy,et al. Regulation of the human IgE receptor (Fc epsilonRII/CD23) by Epstein-Barr virus (EBV): Ku autoantigen binds specifically to an EBV-responsive enhancer of CD23. , 1997, International immunology.
[21] E. Kieff. Epstein-Barr virus and its replication , 1996 .
[22] J. Hsieh,et al. Masking of the CBF1/RBPJ kappa transcriptional repression domain by Epstein-Barr virus EBNA2. , 1995, Science.
[23] J. Lacy,et al. Regulation of the human IgE receptor (Fc epsilon RII/CD23) by EBV. Localization of an intron EBV-responsive enhancer and characterization of its cognate GC-box binding factors. , 1994, Journal of Immunology.
[24] L. Strobl,et al. Crucial sequences within the Epstein-Barr virus TP1 promoter for EBNA2-mediated transactivation and interaction of EBNA2 with its responsive element , 1994, Journal of virology.
[25] J. Hsieh,et al. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1 , 1994, Journal of virology.
[26] J. Lacy,et al. Transcriptional regulation of the human IgE receptor (Fc epsilon RII/CD23) by EBV. Identification of EBV-responsive regulatory elements in intron 1. , 1992, Journal of immunology.
[27] I. Ernberg,et al. Host-cell-phenotype-dependent control of the BCR2/BWR1 promoter complex regulates the expression of Epstein-Barr virus nuclear antigens 2-6. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[28] E. Kieff,et al. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23 , 1990, Journal of virology.
[29] G. Texidó,et al. Expression of human lymphocyte IgE receptor (Fc epsilon RII/CD23). Identification of the Fc epsilon RIIa promoter and its functional analysis in B lymphocytes. , 1989, Journal of immunology.
[30] H. Kikutani,et al. Two species of human Fcε receptor II ( FcεRII CD23 ): Tissue-specific and IL-4-specific regulation of gene expression , 1988, Cell.
[31] B. Barrell,et al. Sequence analysis of Raji Epstein-Barr virus DNA. , 1988, Virology.
[32] R. Bastos,et al. Molecular structure of the gene and the 5'-flanking region of the human lymphocyte immunoglobulin E receptor. , 1987, Nucleic acids research.
[33] S. Swendeman,et al. The activation antigen BLAST‐2, when shed, is an autocrine BCGF for normal and transformed B cells. , 1987, The EMBO journal.
[34] D. Thorley-Lawson,et al. Early events in Epstein-Barr virus infection provide a model for B cell activation , 1985, The Journal of experimental medicine.
[35] R. Schooley,et al. BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus. , 1985, Journal of immunology.
[36] P. L. Deininger,et al. DNA sequence and expression of the B95-8 Epstein—Barr virus genome , 1984, Nature.
[37] B. Griffin,et al. The EB virus genome in Daudi Burkitt's lymphoma cells has a deletion similar to that observed in a non‐transforming strain (P3HR‐1) of the virus. , 1984, The EMBO journal.